There may be a little more ethnic variation in the relationship between Lp(a) level and atherosclerotic cardiovascular disease (ASCVD) risk than previously thought, according to an analysis of data from the HELIUS cohort of 24,780 adults of African Surinamese, Dutch, Ghanaian, Moroccan, South Asian Surinamese and Turkish ethnicity.
Educational Partners and Supporters
AstraZeneca has provided a sponsorship grant towards this independent programme.
(Founding Partner)
Novartis has provided with arm’s length sponsorship towards the set-up of the Lp(a) Forum. The content was developed independently by the Forum.
